Global Rabies Immune Globulin (Human) Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Rabies Immune Globulin (Human) Market Size was estimated at USD 1563.28 million in 2023 and is projected to reach USD 1978.05 million by 2029, exhibiting a CAGR of 4.00% during the forecast period.
This report provides a deep insight into the global Rabies Immune Globulin (Human) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Rabies Immune Globulin (Human) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Rabies Immune Globulin (Human) market in any manner.
Global Rabies Immune Globulin (Human) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Sanofi
Kamada
Bharat Serum
Bio Products Laboratory
Shanghai RAAS
Weiguang Bio
Shuanglin Bio
CBPO
CNBG
Sichuan Yuanda Shuyang
Kedrion Biopharma
Congruent Pharmachem
hualanbio
Market Segmentation (by Type)
HyperRAB S/D
KEDRAB
Market Segmentation (by Application)
Clinic
Hospital
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rabies Immune Globulin (Human) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Rabies Immune Globulin (Human) Market Size was estimated at USD 1563.28 million in 2023 and is projected to reach USD 1978.05 million by 2029, exhibiting a CAGR of 4.00% during the forecast period.
This report provides a deep insight into the global Rabies Immune Globulin (Human) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Rabies Immune Globulin (Human) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Rabies Immune Globulin (Human) market in any manner.
Global Rabies Immune Globulin (Human) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring
Grifols
Sanofi
Kamada
Bharat Serum
Bio Products Laboratory
Shanghai RAAS
Weiguang Bio
Shuanglin Bio
CBPO
CNBG
Sichuan Yuanda Shuyang
Kedrion Biopharma
Congruent Pharmachem
hualanbio
Market Segmentation (by Type)
HyperRAB S/D
KEDRAB
Market Segmentation (by Application)
Clinic
Hospital
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Rabies Immune Globulin (Human) Market
- Overview of the regional outlook of the Rabies Immune Globulin (Human) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rabies Immune Globulin (Human) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Rabies Immune Globulin (Human)
1.2 Key Market Segments
1.2.1 Rabies Immune Globulin (Human) Segment by Type
1.2.2 Rabies Immune Globulin (Human) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RABIES IMMUNE GLOBULIN (HUMAN) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rabies Immune Globulin (Human) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Rabies Immune Globulin (Human) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RABIES IMMUNE GLOBULIN (HUMAN) MARKET COMPETITIVE LANDSCAPE
3.1 Global Rabies Immune Globulin (Human) Sales by Manufacturers (2019-2024)
3.2 Global Rabies Immune Globulin (Human) Revenue Market Share by Manufacturers (2019-2024)
3.3 Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Rabies Immune Globulin (Human) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Rabies Immune Globulin (Human) Sales Sites, Area Served, Product Type
3.6 Rabies Immune Globulin (Human) Market Competitive Situation and Trends
3.6.1 Rabies Immune Globulin (Human) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Rabies Immune Globulin (Human) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RABIES IMMUNE GLOBULIN (HUMAN) INDUSTRY CHAIN ANALYSIS
4.1 Rabies Immune Globulin (Human) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RABIES IMMUNE GLOBULIN (HUMAN) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RABIES IMMUNE GLOBULIN (HUMAN) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rabies Immune Globulin (Human) Sales Market Share by Type (2019-2024)
6.3 Global Rabies Immune Globulin (Human) Market Size Market Share by Type (2019-2024)
6.4 Global Rabies Immune Globulin (Human) Price by Type (2019-2024)
7 RABIES IMMUNE GLOBULIN (HUMAN) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rabies Immune Globulin (Human) Market Sales by Application (2019-2024)
7.3 Global Rabies Immune Globulin (Human) Market Size (M USD) by Application (2019-2024)
7.4 Global Rabies Immune Globulin (Human) Sales Growth Rate by Application (2019-2024)
8 RABIES IMMUNE GLOBULIN (HUMAN) MARKET SEGMENTATION BY REGION
8.1 Global Rabies Immune Globulin (Human) Sales by Region
8.1.1 Global Rabies Immune Globulin (Human) Sales by Region
8.1.2 Global Rabies Immune Globulin (Human) Sales Market Share by Region
8.2 North America
8.2.1 North America Rabies Immune Globulin (Human) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rabies Immune Globulin (Human) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Rabies Immune Globulin (Human) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rabies Immune Globulin (Human) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rabies Immune Globulin (Human) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring
9.1.1 CSL Behring Rabies Immune Globulin (Human) Basic Information
9.1.2 CSL Behring Rabies Immune Globulin (Human) Product Overview
9.1.3 CSL Behring Rabies Immune Globulin (Human) Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Rabies Immune Globulin (Human) SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Rabies Immune Globulin (Human) Basic Information
9.2.2 Grifols Rabies Immune Globulin (Human) Product Overview
9.2.3 Grifols Rabies Immune Globulin (Human) Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Rabies Immune Globulin (Human) SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Sanofi
9.3.1 Sanofi Rabies Immune Globulin (Human) Basic Information
9.3.2 Sanofi Rabies Immune Globulin (Human) Product Overview
9.3.3 Sanofi Rabies Immune Globulin (Human) Product Market Performance
9.3.4 Sanofi Rabies Immune Globulin (Human) SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Kamada
9.4.1 Kamada Rabies Immune Globulin (Human) Basic Information
9.4.2 Kamada Rabies Immune Globulin (Human) Product Overview
9.4.3 Kamada Rabies Immune Globulin (Human) Product Market Performance
9.4.4 Kamada Business Overview
9.4.5 Kamada Recent Developments
9.5 Bharat Serum
9.5.1 Bharat Serum Rabies Immune Globulin (Human) Basic Information
9.5.2 Bharat Serum Rabies Immune Globulin (Human) Product Overview
9.5.3 Bharat Serum Rabies Immune Globulin (Human) Product Market Performance
9.5.4 Bharat Serum Business Overview
9.5.5 Bharat Serum Recent Developments
9.6 Bio Products Laboratory
9.6.1 Bio Products Laboratory Rabies Immune Globulin (Human) Basic Information
9.6.2 Bio Products Laboratory Rabies Immune Globulin (Human) Product Overview
9.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Product Market Performance
9.6.4 Bio Products Laboratory Business Overview
9.6.5 Bio Products Laboratory Recent Developments
9.7 Shanghai RAAS
9.7.1 Shanghai RAAS Rabies Immune Globulin (Human) Basic Information
9.7.2 Shanghai RAAS Rabies Immune Globulin (Human) Product Overview
9.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Product Market Performance
9.7.4 Shanghai RAAS Business Overview
9.7.5 Shanghai RAAS Recent Developments
9.8 Weiguang Bio
9.8.1 Weiguang Bio Rabies Immune Globulin (Human) Basic Information
9.8.2 Weiguang Bio Rabies Immune Globulin (Human) Product Overview
9.8.3 Weiguang Bio Rabies Immune Globulin (Human) Product Market Performance
9.8.4 Weiguang Bio Business Overview
9.8.5 Weiguang Bio Recent Developments
9.9 Shuanglin Bio
9.9.1 Shuanglin Bio Rabies Immune Globulin (Human) Basic Information
9.9.2 Shuanglin Bio Rabies Immune Globulin (Human) Product Overview
9.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Product Market Performance
9.9.4 Shuanglin Bio Business Overview
9.9.5 Shuanglin Bio Recent Developments
9.10 CBPO
9.10.1 CBPO Rabies Immune Globulin (Human) Basic Information
9.10.2 CBPO Rabies Immune Globulin (Human) Product Overview
9.10.3 CBPO Rabies Immune Globulin (Human) Product Market Performance
9.10.4 CBPO Business Overview
9.10.5 CBPO Recent Developments
9.11 CNBG
9.11.1 CNBG Rabies Immune Globulin (Human) Basic Information
9.11.2 CNBG Rabies Immune Globulin (Human) Product Overview
9.11.3 CNBG Rabies Immune Globulin (Human) Product Market Performance
9.11.4 CNBG Business Overview
9.11.5 CNBG Recent Developments
9.12 Sichuan Yuanda Shuyang
9.12.1 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Basic Information
9.12.2 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Overview
9.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Market Performance
9.12.4 Sichuan Yuanda Shuyang Business Overview
9.12.5 Sichuan Yuanda Shuyang Recent Developments
9.13 Kedrion Biopharma
9.13.1 Kedrion Biopharma Rabies Immune Globulin (Human) Basic Information
9.13.2 Kedrion Biopharma Rabies Immune Globulin (Human) Product Overview
9.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Product Market Performance
9.13.4 Kedrion Biopharma Business Overview
9.13.5 Kedrion Biopharma Recent Developments
9.14 Congruent Pharmachem
9.14.1 Congruent Pharmachem Rabies Immune Globulin (Human) Basic Information
9.14.2 Congruent Pharmachem Rabies Immune Globulin (Human) Product Overview
9.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Product Market Performance
9.14.4 Congruent Pharmachem Business Overview
9.14.5 Congruent Pharmachem Recent Developments
9.15 hualanbio
9.15.1 hualanbio Rabies Immune Globulin (Human) Basic Information
9.15.2 hualanbio Rabies Immune Globulin (Human) Product Overview
9.15.3 hualanbio Rabies Immune Globulin (Human) Product Market Performance
9.15.4 hualanbio Business Overview
9.15.5 hualanbio Recent Developments
10 RABIES IMMUNE GLOBULIN (HUMAN) MARKET FORECAST BY REGION
10.1 Global Rabies Immune Globulin (Human) Market Size Forecast
10.2 Global Rabies Immune Globulin (Human) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rabies Immune Globulin (Human) Market Size Forecast by Country
10.2.3 Asia Pacific Rabies Immune Globulin (Human) Market Size Forecast by Region
10.2.4 South America Rabies Immune Globulin (Human) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Rabies Immune Globulin (Human) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Rabies Immune Globulin (Human) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Rabies Immune Globulin (Human) by Type (2025-2030)
11.1.2 Global Rabies Immune Globulin (Human) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Rabies Immune Globulin (Human) by Type (2025-2030)
11.2 Global Rabies Immune Globulin (Human) Market Forecast by Application (2025-2030)
11.2.1 Global Rabies Immune Globulin (Human) Sales (Kilotons) Forecast by Application
11.2.2 Global Rabies Immune Globulin (Human) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Rabies Immune Globulin (Human)
1.2 Key Market Segments
1.2.1 Rabies Immune Globulin (Human) Segment by Type
1.2.2 Rabies Immune Globulin (Human) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RABIES IMMUNE GLOBULIN (HUMAN) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Rabies Immune Globulin (Human) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Rabies Immune Globulin (Human) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RABIES IMMUNE GLOBULIN (HUMAN) MARKET COMPETITIVE LANDSCAPE
3.1 Global Rabies Immune Globulin (Human) Sales by Manufacturers (2019-2024)
3.2 Global Rabies Immune Globulin (Human) Revenue Market Share by Manufacturers (2019-2024)
3.3 Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Rabies Immune Globulin (Human) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Rabies Immune Globulin (Human) Sales Sites, Area Served, Product Type
3.6 Rabies Immune Globulin (Human) Market Competitive Situation and Trends
3.6.1 Rabies Immune Globulin (Human) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Rabies Immune Globulin (Human) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RABIES IMMUNE GLOBULIN (HUMAN) INDUSTRY CHAIN ANALYSIS
4.1 Rabies Immune Globulin (Human) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RABIES IMMUNE GLOBULIN (HUMAN) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RABIES IMMUNE GLOBULIN (HUMAN) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rabies Immune Globulin (Human) Sales Market Share by Type (2019-2024)
6.3 Global Rabies Immune Globulin (Human) Market Size Market Share by Type (2019-2024)
6.4 Global Rabies Immune Globulin (Human) Price by Type (2019-2024)
7 RABIES IMMUNE GLOBULIN (HUMAN) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rabies Immune Globulin (Human) Market Sales by Application (2019-2024)
7.3 Global Rabies Immune Globulin (Human) Market Size (M USD) by Application (2019-2024)
7.4 Global Rabies Immune Globulin (Human) Sales Growth Rate by Application (2019-2024)
8 RABIES IMMUNE GLOBULIN (HUMAN) MARKET SEGMENTATION BY REGION
8.1 Global Rabies Immune Globulin (Human) Sales by Region
8.1.1 Global Rabies Immune Globulin (Human) Sales by Region
8.1.2 Global Rabies Immune Globulin (Human) Sales Market Share by Region
8.2 North America
8.2.1 North America Rabies Immune Globulin (Human) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rabies Immune Globulin (Human) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Rabies Immune Globulin (Human) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rabies Immune Globulin (Human) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rabies Immune Globulin (Human) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring
9.1.1 CSL Behring Rabies Immune Globulin (Human) Basic Information
9.1.2 CSL Behring Rabies Immune Globulin (Human) Product Overview
9.1.3 CSL Behring Rabies Immune Globulin (Human) Product Market Performance
9.1.4 CSL Behring Business Overview
9.1.5 CSL Behring Rabies Immune Globulin (Human) SWOT Analysis
9.1.6 CSL Behring Recent Developments
9.2 Grifols
9.2.1 Grifols Rabies Immune Globulin (Human) Basic Information
9.2.2 Grifols Rabies Immune Globulin (Human) Product Overview
9.2.3 Grifols Rabies Immune Globulin (Human) Product Market Performance
9.2.4 Grifols Business Overview
9.2.5 Grifols Rabies Immune Globulin (Human) SWOT Analysis
9.2.6 Grifols Recent Developments
9.3 Sanofi
9.3.1 Sanofi Rabies Immune Globulin (Human) Basic Information
9.3.2 Sanofi Rabies Immune Globulin (Human) Product Overview
9.3.3 Sanofi Rabies Immune Globulin (Human) Product Market Performance
9.3.4 Sanofi Rabies Immune Globulin (Human) SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Kamada
9.4.1 Kamada Rabies Immune Globulin (Human) Basic Information
9.4.2 Kamada Rabies Immune Globulin (Human) Product Overview
9.4.3 Kamada Rabies Immune Globulin (Human) Product Market Performance
9.4.4 Kamada Business Overview
9.4.5 Kamada Recent Developments
9.5 Bharat Serum
9.5.1 Bharat Serum Rabies Immune Globulin (Human) Basic Information
9.5.2 Bharat Serum Rabies Immune Globulin (Human) Product Overview
9.5.3 Bharat Serum Rabies Immune Globulin (Human) Product Market Performance
9.5.4 Bharat Serum Business Overview
9.5.5 Bharat Serum Recent Developments
9.6 Bio Products Laboratory
9.6.1 Bio Products Laboratory Rabies Immune Globulin (Human) Basic Information
9.6.2 Bio Products Laboratory Rabies Immune Globulin (Human) Product Overview
9.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Product Market Performance
9.6.4 Bio Products Laboratory Business Overview
9.6.5 Bio Products Laboratory Recent Developments
9.7 Shanghai RAAS
9.7.1 Shanghai RAAS Rabies Immune Globulin (Human) Basic Information
9.7.2 Shanghai RAAS Rabies Immune Globulin (Human) Product Overview
9.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Product Market Performance
9.7.4 Shanghai RAAS Business Overview
9.7.5 Shanghai RAAS Recent Developments
9.8 Weiguang Bio
9.8.1 Weiguang Bio Rabies Immune Globulin (Human) Basic Information
9.8.2 Weiguang Bio Rabies Immune Globulin (Human) Product Overview
9.8.3 Weiguang Bio Rabies Immune Globulin (Human) Product Market Performance
9.8.4 Weiguang Bio Business Overview
9.8.5 Weiguang Bio Recent Developments
9.9 Shuanglin Bio
9.9.1 Shuanglin Bio Rabies Immune Globulin (Human) Basic Information
9.9.2 Shuanglin Bio Rabies Immune Globulin (Human) Product Overview
9.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Product Market Performance
9.9.4 Shuanglin Bio Business Overview
9.9.5 Shuanglin Bio Recent Developments
9.10 CBPO
9.10.1 CBPO Rabies Immune Globulin (Human) Basic Information
9.10.2 CBPO Rabies Immune Globulin (Human) Product Overview
9.10.3 CBPO Rabies Immune Globulin (Human) Product Market Performance
9.10.4 CBPO Business Overview
9.10.5 CBPO Recent Developments
9.11 CNBG
9.11.1 CNBG Rabies Immune Globulin (Human) Basic Information
9.11.2 CNBG Rabies Immune Globulin (Human) Product Overview
9.11.3 CNBG Rabies Immune Globulin (Human) Product Market Performance
9.11.4 CNBG Business Overview
9.11.5 CNBG Recent Developments
9.12 Sichuan Yuanda Shuyang
9.12.1 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Basic Information
9.12.2 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Overview
9.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Market Performance
9.12.4 Sichuan Yuanda Shuyang Business Overview
9.12.5 Sichuan Yuanda Shuyang Recent Developments
9.13 Kedrion Biopharma
9.13.1 Kedrion Biopharma Rabies Immune Globulin (Human) Basic Information
9.13.2 Kedrion Biopharma Rabies Immune Globulin (Human) Product Overview
9.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Product Market Performance
9.13.4 Kedrion Biopharma Business Overview
9.13.5 Kedrion Biopharma Recent Developments
9.14 Congruent Pharmachem
9.14.1 Congruent Pharmachem Rabies Immune Globulin (Human) Basic Information
9.14.2 Congruent Pharmachem Rabies Immune Globulin (Human) Product Overview
9.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Product Market Performance
9.14.4 Congruent Pharmachem Business Overview
9.14.5 Congruent Pharmachem Recent Developments
9.15 hualanbio
9.15.1 hualanbio Rabies Immune Globulin (Human) Basic Information
9.15.2 hualanbio Rabies Immune Globulin (Human) Product Overview
9.15.3 hualanbio Rabies Immune Globulin (Human) Product Market Performance
9.15.4 hualanbio Business Overview
9.15.5 hualanbio Recent Developments
10 RABIES IMMUNE GLOBULIN (HUMAN) MARKET FORECAST BY REGION
10.1 Global Rabies Immune Globulin (Human) Market Size Forecast
10.2 Global Rabies Immune Globulin (Human) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rabies Immune Globulin (Human) Market Size Forecast by Country
10.2.3 Asia Pacific Rabies Immune Globulin (Human) Market Size Forecast by Region
10.2.4 South America Rabies Immune Globulin (Human) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Rabies Immune Globulin (Human) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Rabies Immune Globulin (Human) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Rabies Immune Globulin (Human) by Type (2025-2030)
11.1.2 Global Rabies Immune Globulin (Human) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Rabies Immune Globulin (Human) by Type (2025-2030)
11.2 Global Rabies Immune Globulin (Human) Market Forecast by Application (2025-2030)
11.2.1 Global Rabies Immune Globulin (Human) Sales (Kilotons) Forecast by Application
11.2.2 Global Rabies Immune Globulin (Human) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rabies Immune Globulin (Human) Market Size Comparison by Region (M USD)
Table 5. Global Rabies Immune Globulin (Human) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Rabies Immune Globulin (Human) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Rabies Immune Globulin (Human) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Rabies Immune Globulin (Human) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Human) as of 2022)
Table 10. Global Market Rabies Immune Globulin (Human) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Rabies Immune Globulin (Human) Sales Sites and Area Served
Table 12. Manufacturers Rabies Immune Globulin (Human) Product Type
Table 13. Global Rabies Immune Globulin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Rabies Immune Globulin (Human)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Rabies Immune Globulin (Human) Market Challenges
Table 22. Global Rabies Immune Globulin (Human) Sales by Type (Kilotons)
Table 23. Global Rabies Immune Globulin (Human) Market Size by Type (M USD)
Table 24. Global Rabies Immune Globulin (Human) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Rabies Immune Globulin (Human) Sales Market Share by Type (2019-2024)
Table 26. Global Rabies Immune Globulin (Human) Market Size (M USD) by Type (2019-2024)
Table 27. Global Rabies Immune Globulin (Human) Market Size Share by Type (2019-2024)
Table 28. Global Rabies Immune Globulin (Human) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Rabies Immune Globulin (Human) Sales (Kilotons) by Application
Table 30. Global Rabies Immune Globulin (Human) Market Size by Application
Table 31. Global Rabies Immune Globulin (Human) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Rabies Immune Globulin (Human) Sales Market Share by Application (2019-2024)
Table 33. Global Rabies Immune Globulin (Human) Sales by Application (2019-2024) & (M USD)
Table 34. Global Rabies Immune Globulin (Human) Market Share by Application (2019-2024)
Table 35. Global Rabies Immune Globulin (Human) Sales Growth Rate by Application (2019-2024)
Table 36. Global Rabies Immune Globulin (Human) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2019-2024)
Table 38. North America Rabies Immune Globulin (Human) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Rabies Immune Globulin (Human) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Rabies Immune Globulin (Human) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Rabies Immune Globulin (Human) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Rabies Immune Globulin (Human) Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Behring Rabies Immune Globulin (Human) Basic Information
Table 44. CSL Behring Rabies Immune Globulin (Human) Product Overview
Table 45. CSL Behring Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Behring Business Overview
Table 47. CSL Behring Rabies Immune Globulin (Human) SWOT Analysis
Table 48. CSL Behring Recent Developments
Table 49. Grifols Rabies Immune Globulin (Human) Basic Information
Table 50. Grifols Rabies Immune Globulin (Human) Product Overview
Table 51. Grifols Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Rabies Immune Globulin (Human) SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Sanofi Rabies Immune Globulin (Human) Basic Information
Table 56. Sanofi Rabies Immune Globulin (Human) Product Overview
Table 57. Sanofi Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Rabies Immune Globulin (Human) SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Kamada Rabies Immune Globulin (Human) Basic Information
Table 62. Kamada Rabies Immune Globulin (Human) Product Overview
Table 63. Kamada Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kamada Business Overview
Table 65. Kamada Recent Developments
Table 66. Bharat Serum Rabies Immune Globulin (Human) Basic Information
Table 67. Bharat Serum Rabies Immune Globulin (Human) Product Overview
Table 68. Bharat Serum Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bharat Serum Business Overview
Table 70. Bharat Serum Recent Developments
Table 71. Bio Products Laboratory Rabies Immune Globulin (Human) Basic Information
Table 72. Bio Products Laboratory Rabies Immune Globulin (Human) Product Overview
Table 73. Bio Products Laboratory Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bio Products Laboratory Business Overview
Table 75. Bio Products Laboratory Recent Developments
Table 76. Shanghai RAAS Rabies Immune Globulin (Human) Basic Information
Table 77. Shanghai RAAS Rabies Immune Globulin (Human) Product Overview
Table 78. Shanghai RAAS Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai RAAS Business Overview
Table 80. Shanghai RAAS Recent Developments
Table 81. Weiguang Bio Rabies Immune Globulin (Human) Basic Information
Table 82. Weiguang Bio Rabies Immune Globulin (Human) Product Overview
Table 83. Weiguang Bio Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Weiguang Bio Business Overview
Table 85. Weiguang Bio Recent Developments
Table 86. Shuanglin Bio Rabies Immune Globulin (Human) Basic Information
Table 87. Shuanglin Bio Rabies Immune Globulin (Human) Product Overview
Table 88. Shuanglin Bio Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shuanglin Bio Business Overview
Table 90. Shuanglin Bio Recent Developments
Table 91. CBPO Rabies Immune Globulin (Human) Basic Information
Table 92. CBPO Rabies Immune Globulin (Human) Product Overview
Table 93. CBPO Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CBPO Business Overview
Table 95. CBPO Recent Developments
Table 96. CNBG Rabies Immune Globulin (Human) Basic Information
Table 97. CNBG Rabies Immune Globulin (Human) Product Overview
Table 98. CNBG Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. CNBG Business Overview
Table 100. CNBG Recent Developments
Table 101. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Basic Information
Table 102. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Overview
Table 103. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Sichuan Yuanda Shuyang Business Overview
Table 105. Sichuan Yuanda Shuyang Recent Developments
Table 106. Kedrion Biopharma Rabies Immune Globulin (Human) Basic Information
Table 107. Kedrion Biopharma Rabies Immune Globulin (Human) Product Overview
Table 108. Kedrion Biopharma Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Kedrion Biopharma Business Overview
Table 110. Kedrion Biopharma Recent Developments
Table 111. Congruent Pharmachem Rabies Immune Globulin (Human) Basic Information
Table 112. Congruent Pharmachem Rabies Immune Globulin (Human) Product Overview
Table 113. Congruent Pharmachem Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Congruent Pharmachem Business Overview
Table 115. Congruent Pharmachem Recent Developments
Table 116. hualanbio Rabies Immune Globulin (Human) Basic Information
Table 117. hualanbio Rabies Immune Globulin (Human) Product Overview
Table 118. hualanbio Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. hualanbio Business Overview
Table 120. hualanbio Recent Developments
Table 121. Global Rabies Immune Globulin (Human) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Rabies Immune Globulin (Human) Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Rabies Immune Globulin (Human) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Rabies Immune Globulin (Human) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Rabies Immune Globulin (Human) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Rabies Immune Globulin (Human) Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Rabies Immune Globulin (Human) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Rabies Immune Globulin (Human) Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Rabies Immune Globulin (Human) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Rabies Immune Globulin (Human) Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Rabies Immune Globulin (Human) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Rabies Immune Globulin (Human) Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Rabies Immune Globulin (Human) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Rabies Immune Globulin (Human) Market Size Comparison by Region (M USD)
Table 5. Global Rabies Immune Globulin (Human) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Rabies Immune Globulin (Human) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Rabies Immune Globulin (Human) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Rabies Immune Globulin (Human) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Human) as of 2022)
Table 10. Global Market Rabies Immune Globulin (Human) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Rabies Immune Globulin (Human) Sales Sites and Area Served
Table 12. Manufacturers Rabies Immune Globulin (Human) Product Type
Table 13. Global Rabies Immune Globulin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Rabies Immune Globulin (Human)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Rabies Immune Globulin (Human) Market Challenges
Table 22. Global Rabies Immune Globulin (Human) Sales by Type (Kilotons)
Table 23. Global Rabies Immune Globulin (Human) Market Size by Type (M USD)
Table 24. Global Rabies Immune Globulin (Human) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Rabies Immune Globulin (Human) Sales Market Share by Type (2019-2024)
Table 26. Global Rabies Immune Globulin (Human) Market Size (M USD) by Type (2019-2024)
Table 27. Global Rabies Immune Globulin (Human) Market Size Share by Type (2019-2024)
Table 28. Global Rabies Immune Globulin (Human) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Rabies Immune Globulin (Human) Sales (Kilotons) by Application
Table 30. Global Rabies Immune Globulin (Human) Market Size by Application
Table 31. Global Rabies Immune Globulin (Human) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Rabies Immune Globulin (Human) Sales Market Share by Application (2019-2024)
Table 33. Global Rabies Immune Globulin (Human) Sales by Application (2019-2024) & (M USD)
Table 34. Global Rabies Immune Globulin (Human) Market Share by Application (2019-2024)
Table 35. Global Rabies Immune Globulin (Human) Sales Growth Rate by Application (2019-2024)
Table 36. Global Rabies Immune Globulin (Human) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2019-2024)
Table 38. North America Rabies Immune Globulin (Human) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Rabies Immune Globulin (Human) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Rabies Immune Globulin (Human) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Rabies Immune Globulin (Human) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Rabies Immune Globulin (Human) Sales by Region (2019-2024) & (Kilotons)
Table 43. CSL Behring Rabies Immune Globulin (Human) Basic Information
Table 44. CSL Behring Rabies Immune Globulin (Human) Product Overview
Table 45. CSL Behring Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. CSL Behring Business Overview
Table 47. CSL Behring Rabies Immune Globulin (Human) SWOT Analysis
Table 48. CSL Behring Recent Developments
Table 49. Grifols Rabies Immune Globulin (Human) Basic Information
Table 50. Grifols Rabies Immune Globulin (Human) Product Overview
Table 51. Grifols Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Grifols Business Overview
Table 53. Grifols Rabies Immune Globulin (Human) SWOT Analysis
Table 54. Grifols Recent Developments
Table 55. Sanofi Rabies Immune Globulin (Human) Basic Information
Table 56. Sanofi Rabies Immune Globulin (Human) Product Overview
Table 57. Sanofi Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Rabies Immune Globulin (Human) SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Kamada Rabies Immune Globulin (Human) Basic Information
Table 62. Kamada Rabies Immune Globulin (Human) Product Overview
Table 63. Kamada Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Kamada Business Overview
Table 65. Kamada Recent Developments
Table 66. Bharat Serum Rabies Immune Globulin (Human) Basic Information
Table 67. Bharat Serum Rabies Immune Globulin (Human) Product Overview
Table 68. Bharat Serum Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bharat Serum Business Overview
Table 70. Bharat Serum Recent Developments
Table 71. Bio Products Laboratory Rabies Immune Globulin (Human) Basic Information
Table 72. Bio Products Laboratory Rabies Immune Globulin (Human) Product Overview
Table 73. Bio Products Laboratory Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bio Products Laboratory Business Overview
Table 75. Bio Products Laboratory Recent Developments
Table 76. Shanghai RAAS Rabies Immune Globulin (Human) Basic Information
Table 77. Shanghai RAAS Rabies Immune Globulin (Human) Product Overview
Table 78. Shanghai RAAS Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai RAAS Business Overview
Table 80. Shanghai RAAS Recent Developments
Table 81. Weiguang Bio Rabies Immune Globulin (Human) Basic Information
Table 82. Weiguang Bio Rabies Immune Globulin (Human) Product Overview
Table 83. Weiguang Bio Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Weiguang Bio Business Overview
Table 85. Weiguang Bio Recent Developments
Table 86. Shuanglin Bio Rabies Immune Globulin (Human) Basic Information
Table 87. Shuanglin Bio Rabies Immune Globulin (Human) Product Overview
Table 88. Shuanglin Bio Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Shuanglin Bio Business Overview
Table 90. Shuanglin Bio Recent Developments
Table 91. CBPO Rabies Immune Globulin (Human) Basic Information
Table 92. CBPO Rabies Immune Globulin (Human) Product Overview
Table 93. CBPO Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CBPO Business Overview
Table 95. CBPO Recent Developments
Table 96. CNBG Rabies Immune Globulin (Human) Basic Information
Table 97. CNBG Rabies Immune Globulin (Human) Product Overview
Table 98. CNBG Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. CNBG Business Overview
Table 100. CNBG Recent Developments
Table 101. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Basic Information
Table 102. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Overview
Table 103. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Sichuan Yuanda Shuyang Business Overview
Table 105. Sichuan Yuanda Shuyang Recent Developments
Table 106. Kedrion Biopharma Rabies Immune Globulin (Human) Basic Information
Table 107. Kedrion Biopharma Rabies Immune Globulin (Human) Product Overview
Table 108. Kedrion Biopharma Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Kedrion Biopharma Business Overview
Table 110. Kedrion Biopharma Recent Developments
Table 111. Congruent Pharmachem Rabies Immune Globulin (Human) Basic Information
Table 112. Congruent Pharmachem Rabies Immune Globulin (Human) Product Overview
Table 113. Congruent Pharmachem Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Congruent Pharmachem Business Overview
Table 115. Congruent Pharmachem Recent Developments
Table 116. hualanbio Rabies Immune Globulin (Human) Basic Information
Table 117. hualanbio Rabies Immune Globulin (Human) Product Overview
Table 118. hualanbio Rabies Immune Globulin (Human) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. hualanbio Business Overview
Table 120. hualanbio Recent Developments
Table 121. Global Rabies Immune Globulin (Human) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Rabies Immune Globulin (Human) Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Rabies Immune Globulin (Human) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Rabies Immune Globulin (Human) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Rabies Immune Globulin (Human) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Rabies Immune Globulin (Human) Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Rabies Immune Globulin (Human) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Rabies Immune Globulin (Human) Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Rabies Immune Globulin (Human) Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Rabies Immune Globulin (Human) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Rabies Immune Globulin (Human) Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Rabies Immune Globulin (Human) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Rabies Immune Globulin (Human) Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Rabies Immune Globulin (Human) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Rabies Immune Globulin (Human)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rabies Immune Globulin (Human) Market Size (M USD), 2019-2030
Figure 5. Global Rabies Immune Globulin (Human) Market Size (M USD) (2019-2030)
Figure 6. Global Rabies Immune Globulin (Human) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rabies Immune Globulin (Human) Market Size by Country (M USD)
Figure 11. Rabies Immune Globulin (Human) Sales Share by Manufacturers in 2023
Figure 12. Global Rabies Immune Globulin (Human) Revenue Share by Manufacturers in 2023
Figure 13. Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Rabies Immune Globulin (Human) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Rabies Immune Globulin (Human) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Rabies Immune Globulin (Human) Market Share by Type
Figure 18. Sales Market Share of Rabies Immune Globulin (Human) by Type (2019-2024)
Figure 19. Sales Market Share of Rabies Immune Globulin (Human) by Type in 2023
Figure 20. Market Size Share of Rabies Immune Globulin (Human) by Type (2019-2024)
Figure 21. Market Size Market Share of Rabies Immune Globulin (Human) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Rabies Immune Globulin (Human) Market Share by Application
Figure 24. Global Rabies Immune Globulin (Human) Sales Market Share by Application (2019-2024)
Figure 25. Global Rabies Immune Globulin (Human) Sales Market Share by Application in 2023
Figure 26. Global Rabies Immune Globulin (Human) Market Share by Application (2019-2024)
Figure 27. Global Rabies Immune Globulin (Human) Market Share by Application in 2023
Figure 28. Global Rabies Immune Globulin (Human) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2019-2024)
Figure 30. North America Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Rabies Immune Globulin (Human) Sales Market Share by Country in 2023
Figure 32. U.S. Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Rabies Immune Globulin (Human) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Rabies Immune Globulin (Human) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Rabies Immune Globulin (Human) Sales Market Share by Country in 2023
Figure 37. Germany Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Rabies Immune Globulin (Human) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Rabies Immune Globulin (Human) Sales Market Share by Region in 2023
Figure 44. China Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Rabies Immune Globulin (Human) Sales and Growth Rate (Kilotons)
Figure 50. South America Rabies Immune Globulin (Human) Sales Market Share by Country in 2023
Figure 51. Brazil Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Rabies Immune Globulin (Human) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Rabies Immune Globulin (Human) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Rabies Immune Globulin (Human) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Rabies Immune Globulin (Human) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Rabies Immune Globulin (Human) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Rabies Immune Globulin (Human) Market Share Forecast by Type (2025-2030)
Figure 65. Global Rabies Immune Globulin (Human) Sales Forecast by Application (2025-2030)
Figure 66. Global Rabies Immune Globulin (Human) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Rabies Immune Globulin (Human)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Rabies Immune Globulin (Human) Market Size (M USD), 2019-2030
Figure 5. Global Rabies Immune Globulin (Human) Market Size (M USD) (2019-2030)
Figure 6. Global Rabies Immune Globulin (Human) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Rabies Immune Globulin (Human) Market Size by Country (M USD)
Figure 11. Rabies Immune Globulin (Human) Sales Share by Manufacturers in 2023
Figure 12. Global Rabies Immune Globulin (Human) Revenue Share by Manufacturers in 2023
Figure 13. Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Rabies Immune Globulin (Human) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Rabies Immune Globulin (Human) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Rabies Immune Globulin (Human) Market Share by Type
Figure 18. Sales Market Share of Rabies Immune Globulin (Human) by Type (2019-2024)
Figure 19. Sales Market Share of Rabies Immune Globulin (Human) by Type in 2023
Figure 20. Market Size Share of Rabies Immune Globulin (Human) by Type (2019-2024)
Figure 21. Market Size Market Share of Rabies Immune Globulin (Human) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Rabies Immune Globulin (Human) Market Share by Application
Figure 24. Global Rabies Immune Globulin (Human) Sales Market Share by Application (2019-2024)
Figure 25. Global Rabies Immune Globulin (Human) Sales Market Share by Application in 2023
Figure 26. Global Rabies Immune Globulin (Human) Market Share by Application (2019-2024)
Figure 27. Global Rabies Immune Globulin (Human) Market Share by Application in 2023
Figure 28. Global Rabies Immune Globulin (Human) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2019-2024)
Figure 30. North America Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Rabies Immune Globulin (Human) Sales Market Share by Country in 2023
Figure 32. U.S. Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Rabies Immune Globulin (Human) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Rabies Immune Globulin (Human) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Rabies Immune Globulin (Human) Sales Market Share by Country in 2023
Figure 37. Germany Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Rabies Immune Globulin (Human) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Rabies Immune Globulin (Human) Sales Market Share by Region in 2023
Figure 44. China Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Rabies Immune Globulin (Human) Sales and Growth Rate (Kilotons)
Figure 50. South America Rabies Immune Globulin (Human) Sales Market Share by Country in 2023
Figure 51. Brazil Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Rabies Immune Globulin (Human) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Rabies Immune Globulin (Human) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Rabies Immune Globulin (Human) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Rabies Immune Globulin (Human) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Rabies Immune Globulin (Human) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Rabies Immune Globulin (Human) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Rabies Immune Globulin (Human) Market Share Forecast by Type (2025-2030)
Figure 65. Global Rabies Immune Globulin (Human) Sales Forecast by Application (2025-2030)
Figure 66. Global Rabies Immune Globulin (Human) Market Share Forecast by Application (2025-2030)
